Eisenhut M, Omari A A A
University of Liverpool, 5 Prestwood Crescent, Liverpool, UK, L14 2ED.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004009. doi: 10.1002/14651858.CD004009.pub2.
In children with falciparum malaria, quinine administered rectally may be easier to use and less painful than intramuscular or intravenous administration. However, it may be less effective.
To compare intrarectal quinine with intravenous or intramuscular quinine for treating malaria caused by Plasmodium falciparum.
We searched the Cochrane Infectious Diseases Group Specialized Register (July 2004), CENTRAL (The Cochrane Library Issue 3, 2004), MEDLINE (1966 to July 2004), EMBASE (1974 to July 2004), LILACS (1982 to July 2004), and CINAHL (1982 to July 2004). We also searched conference proceedings, contacted individual researchers and a pharmaceutical company, and checked reference lists.
Randomized and quasi-randomized controlled trials comparing intrarectal quinine with intramuscular and intravenous quinine for treating people with uncomplicated and severe falciparum malaria.
We independently assessed trial quality and extracted data, including adverse event data. We analysed dichotomous data using odds ratios and weighted mean difference for continuous data.
Eight randomized controlled trials (involving 1247 children) fulfilled the inclusion criteria. The same principal investigator led seven of the trials. Five trials compared intrarectal with intravenous quinine, and six trials compared it with intramuscular treatment. We detected no statistically significant difference between intrarectal and intravenous or intramuscular routes for death, parasite clearance by 48 hours and 7 days, parasite clearance time, fever clearance time, coma recovery time, duration of hospitalization, and time to drinking. The trials reporting on these outcomes were small, which resulted in large confidence intervals for all outcomes apart from duration of hospitalization. One large trial (898 children) reported that intrarectal was less painful than intramuscular administration.
AUTHORS' CONCLUSIONS: We detected no difference in the effect on parasites and clinical illness for intrarectal quinine, but most trials were small. Pain may be less with intrarectal quinine. Further larger trials, in patients with severe malaria and in adults, are required before the intrarectal route can be recommended.
在患恶性疟原虫疟疾的儿童中,直肠给予奎宁可能比肌肉注射或静脉注射更易于使用且痛苦更小。然而,其效果可能较差。
比较直肠内给予奎宁与静脉或肌肉注射奎宁治疗恶性疟原虫引起的疟疾的效果。
我们检索了Cochrane传染病专业组专门注册库(2004年7月)、Cochrane系统评价数据库(2004年第3期)、医学索引数据库(1966年至2004年7月)、荷兰医学文摘数据库(1974年至2004年7月)、拉丁美洲和加勒比卫生科学数据库(1982年至2004年7月)以及护理学与健康照护数据库(1982年至2004年7月)。我们还检索了会议论文集,联系了个别研究人员和一家制药公司,并查阅了参考文献列表。
比较直肠内给予奎宁与肌肉注射和静脉注射奎宁治疗非复杂性和重症恶性疟原虫疟疾患者的随机和半随机对照试验。
我们独立评估试验质量并提取数据,包括不良事件数据。我们使用比值比分析二分数据,对连续数据使用加权均数差。
八项随机对照试验(涉及1247名儿童)符合纳入标准。其中七项试验由同一主要研究者主导。五项试验比较了直肠内给予奎宁与静脉注射奎宁,六项试验比较了直肠内给予奎宁与肌肉注射治疗。在死亡、48小时和7天时的寄生虫清除、寄生虫清除时间、发热清除时间、昏迷恢复时间、住院时间以及开始饮水时间方面,我们未发现直肠内给药与静脉或肌肉注射途径之间存在统计学上的显著差异。报告这些结果的试验规模较小,这导致除住院时间外所有结果的置信区间都很大。一项大型试验(898名儿童)报告称,直肠内给药比肌肉注射痛苦更小。
我们未发现直肠内给予奎宁对寄生虫和临床疾病的影响存在差异,但大多数试验规模较小。直肠内给予奎宁可能痛苦更小。在推荐直肠内给药途径之前,需要在重症疟疾患者和成人中进行进一步的大型试验。